Aditxt, Inc.

NASDAQ (USD): Aditxt, Inc. (ADTX)

Last Price

0.121

Today's Change

+0.009 (8.029%)

Day's Change

0.112 - 0.126

Trading Volume

7,353,562

Overview

Market Cap

1 Million

Shares Outstanding

14 Million

Avg Volume

14,923,688

Avg Price (50 Days)

0.27

Avg Price (200 Days)

37.35

PE Ratio

0.00

EPS

628.80

Earnings Announcement

14-Apr-2025

Previous Close

0.11

Open

0.11

Day's Range

0.1115 - 0.126

Year Range

0.107 - 218.0

Trading Volume

7,777,377

Price Change Highlight

1 Day Change

7.43%

5 Day Change

-16.49%

1 Month Change

-34.92%

3 Month Change

-84.91%

6 Month Change

-99.79%

Ytd Change

-38.46%

1 Year Change

-99.93%

3 Year Change

-100.00%

5 Year Change

-100.00%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment